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Abstract To measure the relative transcription of adenosine
receptor subtypes and the contractile effects of adenosine and
selective receptor-subtype ligands on detrusor smooth muscle
from patients with neuropathic overactive (NDO) and stable
bladders and also from guinea-pigs. Contractile function was
measured at 37°C in vitro from detrusor smooth muscle strips.
Contractions were elicited by superfusate agonists or by elec-
trical field stimulation. Adenosine-receptor (A1, A2A, A2B,
A3) transcription was measured by RT-PCR. Adenosine atten-
uated nerve-mediated responses with equivalent efficacy in
human and guinea-pig tissue (pIC50 3.65–3.86); the action
was more effective at low (1–8 Hz) compared to high (20–
40Hz) stimulation frequencies in human NDO and guinea-pig
tissue. With guinea-pig detrusor the action of adenosine was
mirrored by the A1/A2-agonist N-ethylcarboxamido adeno-
sine (NECA), partly abolished in turn by the A2B-selectve
antagonist alloxazine, as well as the A1-selective agonist
N6- cyclopentyladenosine (CPA). With detrusor from stable
human bladders the effects of NECA and CPA were much
smaller than that of adenosine. Adenosine also attenuated car-
bachol contractures, but mirrored by NECA (in turn blocked
by alloxazine) only in guinea-pig tissue. Adenosine receptor
subtype transcription was measured in human detrusor and
was similar in both groups, except reduced A2A levels in
overactive bladder. Suppression of the carbachol contracture
in human detrusor is independent of A-receptor activation, in
contrast to an A2B-dependent action with guinea-pig tissue.
Adenosine also reduced nerve-mediated contractions, by an
A1- dependent action suppressing ATP neurotransmitter
action.
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Introduction
The purinergic system regulates bladder function through the
action of ATP or its metabolites. ATP and its immediate break-
down product ADP have been extensively studied through
their respective actions on purinergic P2X and P2Y receptors.
ATP is a functional excitatory neurotransmitter in most animal
and also human overactive bladders (Bayliss et al. 1999; Fry et
al., 2011). ATP is also released from urothelium in response to
mechanical and chemical interventions (Ferguson et al. 1997;
Sadananda et al. 2009) and this is greater from tissues obtain-
ed from pathologies such as overactive bladder (Munoz et al.
2011). ADP has a negative inotropic effect on detrusor smooth
muscle (McMurray et al., 1998) but activates suburothelial
interstitial cells and also increases spontaneous bladder con-
tractions (Fry et al. 2012).
Adenosine, a breakdown product of ATP via endonucleo
tidases, is a P1 receptor agonist. It relaxes agonist-induced
detrusor contractions (Rubinstein et al. 1998) and attenuates
stretch-activated urothelial ATP release (Dunning-Davies et
al. 2013). Endonucleotidase activity is reduced in human
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detrusor from overactive bladders (Harvey et al. 2002) and
variation of adenosine levels may have significant conse-
quences on detrusor contractile function. However, its action
on human detrusor from normal or overactive bladders has not
been thoroughly investigated. The P1 class of adenosine re-
ceptors (A1, A2A, A2B and A3) mediate their actions via
different G-protein-coupled intracellular pathways (Ralevic
and Burnstock 1998). This study described the contractile
effects of adenosine, via these receptor subtypes, in isolated
human detrusor from patients with stable bladders and those
with neuropathic detrusor overactivity. In addition, the expres-
sion of P1-receptor subtypes in these samples was measured.
Functional experiments with well-characterised guinea-pig
detrusor were also done to: establish optimal concentrations
of adenosine receptor ligands; and assist with the interpreta-
tion of human detrusor data.
Methods
Tissue samples and ethical approvals Human bladder tissue
was collected with informed and signed patient consent. All
procedures were in accordance with ethical committee ap-
proval of University College London Hospitals, and with the
1964 Helsinki declaration. Biopsies were obtained from the
bladder dome of patients who had: i) bladder carcinoma un-
dergoing cystectomy and symptomatically-stable bladders;
the biopsy was distant from the tumour (n = 16: 9 female; 7
male; age 56 ± 14 yr); ii) spinal cord injury or multiple scle-
rosis undergoing clam ileocystoplasty with urodynamically-
demonstrated neuropathic detrusor overactivity (NDO;
n = 18: 8 female; 10 male; age 33 ± 7 yr). NDO patients were
significantly (p < 0.05) younger than stable bladder patients.
Samples were immediately stored in Ca2+-free HEPES-
Tyrode’s solution, the mucosa removed and portions either
frozen in liquid N2 or used for functional experiments begun
generally 30–60 min after biopsy retrieval, and never more
than two hours. Animal experiments used guinea-pig
(Dunkin-Hartley, males, 350–450 g) bladders removed af-
ter euthanisation by cervical dislocation in accordance
with UK Home Office procedures (UK Animals
(Scientific Procedures) Act, 1986). Animals were housed
two to three per cage with ad libidum access to water and
standard chow in a pathogen-free unit of 12/12 h light-
dark cycle.
Measurement of contractile function Detrusor strips (4–5
mm length, ≤0.5 mm diam.) were tied to an isometric force
transducer and superfused with Tyrode’s solution at 36°C.
Nerve-mediated contractions (TTX-sensitive) were generated
by electrical field stimulation (0.1 ms pulses, 1–40 Hz, 3-s
train every 90-s). Agonist-induced responses were generated
by addition of the muscarinic receptor agonist, carbachol.
Nerve-mediated contraction magnitude, T, as a function of
frequency, f, was fitted to: , where Tmax
is maximum tension at high frequencies and f1/2 the frequency
to attain Tmax/2, n is a constant. Ratios of tension at low (4 Hz)
and near maximum (40 Hz) frequencies (T4/40) for human and
4 Hz and 20 Hz (T4/20) for guinea-pig detrusor were also
calculated. T4/20 was chosen for guinea-pig as T40 contractions
can have a significant TTX-insensitive component, indicative
of direct muscle stimulation, and T20 contractions are near
maximal.
Solutions and reagents Tyrode’s solution contained (mM):
NaCl, 118; KCl, 4.0; NaHCO3, 24; NaH2PO4, 0.4; MgCl2,
1.0; CaCl2, 1.8; glucose, 6.1; Na pyruvate, 5.0; 95%O2,
5%CO2; pH 7.40 ± 0.02. HEPES-Tyrode’s was similar except
NaHCO3 was replaced with HEPES (10 mM) plus NaCl (14
mM), titrated to pH 7.4 with NaOH and gassed with 100%O2.
Stock solutions (1 mM in DMSO) of the selective A-receptor
ligands N-ethylcarboxamidoadenosine (NECA, A1/A2-
selective agonist); N6-cyclopentyladenosine (CPA, A1-
selective agonist); 1,3-dipropyl-8-cyclopentylxanthine
(DPCPX, A1-selective antagonist); CGS 21680 (A2A–selec-
tive agonist); ZM-241,385 (A2A–selective antagonist);
alloxazine (A2B antagonist); IB-MECA (A3–selective ago-
nist): and stock solutions (1–10 mM in Analar grade water)
of atropine, carbachol, adenosine and ABMAwere diluted in
Tyrode’s solution. Test concentrations for adenosine and
NECA were at the higher range of the dose-response curve
(see Results) or similar to those derived from the literature. All
reagents were from Sigma-Aldrich (UK).
Quantification of adenosine receptor expression This was
done by RT-PCR and Western blotting. Details of the meth-
odology and the primers and antibodies used are included in
the supplementary material.
Data and statistics Data are mean ± SD, differences between
data sets were examined with paired or unpaired Student’s t-
tests; the null hypothesis was rejected at p < 0.05. n-values
refer to the number of preparations, one each from separate
patients or animals.
Results
Baseline data: nerve-mediated contractions Table 1 shows
nerve-mediated contraction data and adenosine potency to re-
duce contractions. Maximum tension was similar from human
stable and NDO, and also in guinea-pig detrusor. The frequen-
cy for half-maximum tension, f1/2, was significantly greater
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with detrusor from stable human bladders compared to human
NDO and guinea-pig detrusor: f1/2, values from the latter
groups were not significantly different. Atropine-resistant
contractions in human NDO (Fig 1a inset, upper panel) and
guinea-pig detrusor were abolished by P2X1 receptor
desensitisation with 1 μM ABMA - consistent with ATP as
a functional neurotransmitter. Fig 1a shows force-frequency
plots for detrusor from human stable and NDO (sample in
Table 1 Baseline contraction characteristics. Nerve-mediated contrac-
tions and potency of adenosine to reduce contractions in detrusor smooth
muscle from human and guinea-pig bladders. NDO: neuropathic detrusor
overactivity. Mean data ± SD; *p < 0.05, **p < 0.01 vs NDO human
bladder. Values in parenthesis are the number of preparations
Human stable bladder Human NDO bladder Guinea-pig bladder
Tmax, mN.mm
−2 34.6 ± 21.1 (16) 44.3 ± 22.6 (18) 42.1 ± 13.8 (24)
f1/2, Hz 13.7 ± 4.3 (16) 10.9 ± 2.1 (18) * 9.2 ± 3.9 (24) **
Atropine resistance, % 2.4 ± 1.9 (16) 37.4 ± 22.5 (17) ** 53.8 ± 15.4 (9) **
T4/40 0.102 ± 0.015 (16) 0.140 ± 0.015 (18) ** 0.167 ± 0.062 (24) **
Adenosine pIC50 3.70 ± 0.52 (5) (IC50 = 199 μM) 3.65 ± 0.54 (5) (IC50 = 224 μM) 3.86 ± 0.33 (11) (IC50 = 138 μM)
Fig 1 Force-frequency relations of human detrusor from stable and NDO
bladders. a: force-frequency curves of human detrusor from stable
(n = 16) or NDO (n = 18) bladders, and detrusor from NDO bladders
treated with atropine (atr, n = 17). Inset: upper panel, nerve-mediated
contractions (12 Hz stimulation) from an NDO bladder preparation, atro-
pine was added as shown. The ratio of a*100/b is the atropine resistant
value. Lower panel, a force-frequency response with two of three con-
tractions at each frequency, except a single one at 40 Hz. b: f1/2 values for
detrusor from NDO bladders in the absence (NDO) and presence of
atropine (NDO atr, n = 17). Lines connect values from the same prepa-
rations. c: Values (n = 17) of the ratio T4/40 for human and T4/20 for
guinea-pig detrusor. Human NDO and guinea-pig values are also shown
in the presence of atropine (atr) or ABMA. Values from stable bladder
preparations (n = 16) are also shown; *p < 0.05 vs values in the absence of
atropine or ABMA: #p < 0.05 human stable vs NDO detrusor in the
absence of atropine or ABMA
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inset, lower panel) bladders; the curve for NDO detrusor was
left-shifted and moreover shifted further to the left in the pres-
ence of atropine, with a reduction of f1/2 recorded in 16 of 17
NDO preparations (Fig 1b). A similar reduction of f1/2 by
atropine, from 9.2 ± 3.9 to 6.0 ± 2.5 Hz (n = 24), was seen
in guinea-pig tissue.
The ratio of tension (T) at 4 and 40 Hz stimulation (T4/40)
quantified low and high frequency responses whereby larger
values mean proportionately more tension at 4 Hz compared
to 40 Hz stimulation (Table 1). With human NDO tissue T4/40
was significantly increased by atropine and reduced by
ABMA (Fig 1c). Similar observations were made for
guinea-pig tissue: T4/20 in control was 0.128 ± 0.0448 and
increased by atropine (0.236 ± 0.109, n = 9, p < 0.01) or
decreased by ABMA (0.080 ± 0.030, n = 9, p = 0.005).
With detrusor from stable human bladders the T4/40 ratio was
smaller than that of NDO and guinea-pig tissues, but similar to
the NDO + ABMAvalue (Fig 1c), was unaffected by ABMA
and could not be determined in the presence of atropine, due to
the lack of atropine-resistant contractions. These data are con-
sistent with ATP neurotransmitter release being proportionate-
ly greater compared to acetylcholine at lower stimulation
frequencies.
Contractile effects of adenosine Adenosine reduced the
magnitude of nerve-mediated contractions in a dose-
dependent manner (Table 1), with pIC50 values similar in
human and guinea-pig tissues; a concentration of 1 mM
was used in subsequent experiments. A pIC50 value
(6.27 ± 0.49, n = 10) for the A1/A2 receptor agonist
NECA was also generated with guinea-pig detrusor; a test
value of 10 μM was subsequently used. Adenosine exerted
a frequency-dependent effect on tension reduction in hu-
man NDO (n = 10) and guinea-pig (n = 12) detrusor, where
acetylcholine (ACh) and ATP are both neurotransmitters
(Fig 2). There was a greater action at low frequencies, so
that T4/40 ratios (T4/T20 for guinea-pig deturosr) were sig-
nificantly (p < 0.05) reduced. By contrast there was no
effect on the T4/40 ratio with human stable detrusor
(n = 15) where only ACh is a neurotransmitter. These data
are consistent with the hypothesis that an action of adeno-
sine in guinea pig and NDO human bladders is to reduce
preferentially ATP, rather than ACh, release from the motor
nerve terminal. The action of adenosine via A-receptor
subtypes was further characterised using three modes of
contractile activation: direct detrusor smooth muscle acti-
vation by carbachol (0.3 μM); T40 contractions for those
mediated largely by ACh; T4 contractions for those with a
greater purinergic component.
Adenosine and A-receptor subtype-selective agents:
contractions from human stable bladder detrusor Fig 3
shows data from responses from stable human bladder
detrusor. Adenosine reduced carbachol contractures (top panel
and inset) by about 40%, but this was only partially matched by
the A1/A2-receptor agonist NECA. The effect of NECA was
unaffected by the A2A antagonist ZM-241,385 (ZM; 0.1 μM),
but abolished completely by the A2B antagonist alloxazine
(AL; 1 μM). The A1-selective agonist (CPA, 10 μM) was
without significant effect. The actions of these agents were
mirrored with T40 and T4 contractions (Fig 3, centre and
bottom panels), consistent with the fact that in human stable
bladders nerve-mediated contractions are entirely cholinergic.
ZM-241,385 and alloxazine alone were without effect (data not
shown). The selective agonists to A2A (CGS-21,680, 10 μM)
and A3 (IB-MECA, 10 μM) receptors were also without sig-
nificant effects on any contractile variable.
Adenosine and A-receptor subtype-selective agents:
contractions from human NDO detrusor The pattern of re-
sponses (Fig 4) showed differences from those of stable blad-
der. Adenosine reduced carbachol contractions in NDO
detrusor by a similar amount to detrusor from stable bladders,
however NECA and CPA were both without any significant
effect. Adenosine had a similar effect on T40 contractions
(Fig 4 inset), however it had a much greater action on T4
contractions (p < 0.001; 4 vs 40 Hz). Furthermore, CPA also
reduced nerve-mediated contractions: more on T4 compared to
T40 contractions (p < 0.001; 4 vs 40 Hz); NECA again was
without effect on T40 (inset) or T4 contractions. ZM-241,385,
alloxazine, CGS-21,680 and IB-MECAwere without effect.
Adenosine and A-receptor subtype-selective agents:
contractions from guinea-pig detrusor Fig 5 shows a sim-
ilar protocol, except T20 and T4 contractions were analysed
(see Methods). Reduction by adenosine of the carbachol con-
tracture and T20 contractions were similar to those with human
Fig 2 Frequency-dependent effects of adenosine on nerve-mediated con-
tractions. T4/40 values (T4/T20 for guinea-pig detrusor) in the absence and
presence of adenosine (ado). Data from human NDO, guinea-pig and
human stable bladder preparations. *p < 0.05 in the absence of adenosine
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detrusor. However, in this tissue NECAwas equally effective
(Fig 5 inset), and its own action was unaffected by ZM-241,
385. Alloxazine blocked completely the effect of NECA on
the carbachol contracture and T4 contractions, and was partial-
ly effective on T20 contractions. CPA had no effect on the
carbachol contracture, but did reduce T20 contractions and to
a greater extent T4 contractions, similar to its action on human
NDO detrusor. ZM-241,385, alloxazine, CGS-21,680 and IB-
MECA alone were without effect on any contraction. Control
experiments showed that the selective A1 receptor antagonist,
DPCPX antagonised the effects of CPA and NECA on nerve-
mediated contractions. Schild plots yielded pA2 values of 9.62
and 8.54 respectively for the action of DPCPX, i.e. the Kb
values were 0.24 and 2.9 nM, respectively, similar to those
previously reported (Nicholls et al., 1996).
Adenosine receptor gene transcription in stable and NDO
human bladder samples Stable and NDO samples yielded
similar quantities of RNA (1.40 ± 0.16 vs 1.73 ± 0.60μg.mg−1
respectively, n = 6,7). RNA from each sample was run on two
separate gels and the average value used. Amplified A-
receptor gene products, normalised to their own GAPDH-3
band, showed that the A1 receptor was expressed the least
and A2B/A3 the most (Fig 6a). All receptor subtypes were
equally transcribed in stable and NDO groups, except for
A2A that was significantly reduced in NDO samples.
Adenosine receptor protein expression was measured in the
same samples (n = 6,7). As with gene transcription data, pro-
tein expression of the A1-receptor was very low but with no
difference between the two groups. There was greater expres-
sion of the other receptors and, as above, the A2A level was
significantly reduced in the NDO group, but A2B and A3
levels were similar in the two groups (Fig 6b).
Fig 3 The effect of adenosine and selective A-receptor subtype ligands
on detrusor from human stable bladders. Values are reduction of tension
from control. Three sets of data refer to actions on the carbachol contrac-
ture (top panel); the T40 NM-C centre panel) and T4 Hz NM-C (bottom
panel). Mean data ± SD, *p < 0.05 vs control, **p < 0.01 vs control.
Values above bars are number of preparations. ZM = ZM241385;
AL = alloxazine; CGS = CGS-21,680; IB-M = IB-MECA
Fig 4 The effect of adenosine and selective A-receptor subtype ligands
on detrusor from human NDO bladders. Values are reduction of tension
from control. Three sets of data refer to actions on the carbachol contrac-
ture (left panel); the T40 NM-C centre panel) and the T4 NM-C (right
panel). Mean data ± SD, **p < 0.01 vs control. Values above bars are
number of preparations. ZM = ZM241385; AL = alloxazine;
CGS = CGS-21,680; IB-M = IB-MECA
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Discussion
Frequency-dependence of transmitter release Nerve-medi-
ated detrusor contractions from stable human bladders were
mediated mainly by ACh, but human NDO and guinea-pig
detrusor showed an additional ATP-dependent component
(Bayliss et al. 1999; Fry et al., 2011). ATP-mediated contrac-
tions were more prominent at low stimulation frequencies,
suggesting a frequency-dependent release of ATP and ACh,
as also observed with ATP and noradrenaline release at sym-
pathetic terminals (Westfall et al. 1996; Todorov et al. 1999;
Stjärne 2001). This may underlie the ATP-dependence of the
initial phase of nerve-mediated contractions in some detrusor
preparations (Tsai et al. 2012).
Adenosine and detrusor contractions Adenosine reduced
contractions in all detrusor preparations. Carbachol and T40
(T20 for guinea-pig detrusor) contractions, the latter dominat-
ed by ACh release, were equally reduced by about 40%, as
were T4 contractions from stable bladders. This suggests a
direct effect of adenosine on detrusor muscle (Nicholls et al.
1996; Woods et al. 2003). However, T4 contractions in human
NDO and guinea-pig detrusor were reduced to a greater ex-
tent, consistent with the hypothesis that adenosine additionally
reduced ATP release from motor nerves, similar to its action
on sympathetic nerve terminals (Driessen et al. 1994).
Adenosine receptor subtypes mediating contractile
responses to carbachol The A1/A2 agonist NECA reduced
the carbachol contraction to the same extent as adenosine in
guinea-pig detrusor. However, in human tissue it had a much
smaller effect on stable bladder tissue and none at all in NDO
detrusor. Any negative inotropic effect was abolished by the
A2B receptor antagonist alloxazine, but not by an A2A recep-
tor antagonist, ZM-241,385. An A2A agonist (CGS-21,680)
Fig 5 The effect of adenosine and selective A-receptor subtype ligands
on detrusor from guinea-pig bladders. Values are reduction of tension
from control. Three sets of data refer to actions on the carbachol contrac-
ture (left panel); the T20 NM-C centre panel) and the T4 NM-C (right
panel). Mean data ± SD, *p < 0.05 vs control, **p < 0.01 vs control.
Values above bars are number of preparations. ZM = ZM241385;
AL = alloxazine; CGS = CGS-21,680; IB-M = IB-MECA
Fig 6 Amplified gene products and protein levels for A1, A2A, A2B and
A3 receptors in human detrusor. a: RT-PCR data of adenosine (A) recep-
tor subtype expression in samples from human stable and NDO bladders.
Data are shown as a ratio of GAPDH-3. b: A-receptor subtype protein
levels in samples from human stable and NDO bladders. Data are shown
as a ratio of actin product. *p < 0.05 stable vs NDO; (n = 6,7 for both
parts)
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and an A3 agonist (IB-MECA) were without effect; A2B ag-
onists were not used due to their poor selectivity. These data
suggest that A2B receptors mediate the effect of adenosine in
guinea-pig detrusor, as in other animal smooth muscles
(Nicholls et al. 1996; Aronsson et al., 2010). However, with
human detrusor from stable and NDO bladders A2B receptors
mediate only part of the effect of adenosine or not at all,
respectively. It is possible that the selective adenosine receptor
ligands were less potent, relative to that of adenosine, in hu-
man detrusor, especially from NDO bladders. However,
higher concentrations were equally ineffective (not shown).
These observations demonstrate the uncertainty in extrapolat-
ing data from animal tissue to explain contractile pathways in
human detrusor.
Adenosine receptor subtypes mediating nerve-mediated
contractile responses High-frequency nerve-mediated, T40,
contractions from human stable bladder and NDO bladder
preparations and low-frequency, T4, contractions from stable
bladder are dominated by ACh release. Data were similar to
those obtained by application of carbachol, thus no additional
effect of adenosine on ACh release from motor nerves is pro-
posed. However, T4 contractions from NDO human and
guinea-pig detrusor had a significant ATP-dependent compo-
nent and were reduced by adenosine to a greater extent than
contractions dependent only on ACh.
NECA had a similarly enhanced effect in guinea-pig tissue,
as did the more selective A1-receptor agonist CPA in both
human NDO and guinea-pig tissue. A1 receptors are implied
in regulation of transmitter release from parasympathetic
nerves in human and murine detrusor, although a direct role
on detrusor muscle cannot be excluded (Searl et al., 2016).
These data are consistent with the hypothesis that adenosine
and CPA reduced T4 contractions by limiting preferentially
nerve-mediated release of ATP, rather than ACh. NECA had
an equivalent effect on guinea-pig tissue, but its lack of effect
on human NDO T4 contractions, corroborates its diminished
effect on human detrusor ACh-mediated responses.
The RT-PCR and protein expression data show that vari-
able transcription and expression of A-receptors are unlikely
to underlie different responses to adenosine, and to NECA or
CPA in human detrusor from stable and NDO bladders.
Functional experiments showed that A2B receptors mediated
all or part of the contractile response to adenosine on guinea-
pig and human stable detrusor, and A1 receptors mediated
attenuation of neurotransmitter, predominantly ATP, release.
However, expression and translation of A1, A2B, and also A3
receptors were equivalent in the two groups. Only the A2A
receptor was down-regulated in NDO tissue and this had no
functional counterpart in contractile regulation.
Fig 7 summarises the actions of adenosine on human and
guinea-pig detrusor contractile function. With guinea-pig
detrusor (part a) motor nerve excitation releases acetylcholine
and ATP, both of which exert functional effects on detrusor. In
addition, adenosine as a metabolite of ATP relaxed detrusor
via an A2B receptor and, we propose, attenuated selectively
release of ATP from the motor nerve, via an A1 receptor. With
human detrusor from stable bladders (part b), acetylcholine is
the sole functional transmitter, whereby it acts importantly via
M3 receptors (Chess-Williams et al. 2001) but with a contri-
bution from M2 receptors (Pontari et al., 2004). ATP is
completely hydrolysed (Harvey et al. 2002) and adenosine
could relax detrusor itself. However, in contrast to guinea-
pig detrusor, only in a small part via an A2B receptor, most
of the effect was via a non-A receptor (n/A) pathway. With
NDO bladder detrusor (part c) acetylcholine also acts via M3
receptors and with a larger contribution from M2 receptors
(Pontari et al., 2004). In addition, not all ATP released from
excitatory nerves is hydrolysed and some activates detrusor
via a P2X1 receptor (King et al. 2004). Adenosine relaxed
detrusor exclusively via an n/A pathway and also acted on
the nerve terminal, via an A1 receptor, to attenuate exclusively
Fig 7 A model of the effects of adenosine on nerve-endings and smooth
muscle to modulate contractile function in human and guinea-pig
detrusor. a: Guinea-pig bladder. Acetylcholine (ACh) and ATP bind to
M3 and P2X1 receptors respectively. Adenosine, derived fromATP break-
down in the nerve-muscle junction, binds toA2B (detrusor) andA1 (nerve
endings) receptors. b:Human stable bladder. ACh binds to M3 receptors;
ATP is completely broken down in the nerve-muscle junction. Adenosine
has an effect via non-A receptors (n/A) on detrusor. c: Human NDO
bladder. ACh binds to M3 receptors; ATP is incompletely broken down
and activates detrusor via P2X1 receptors. Adenosine acts on detrusor via
non-A receptors and binds to nerve-terminal A1 receptors. + activation, −
inhibition
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ATP release. In principle, an A1 receptor modulator could be a
drug target for the human overactive bladder (OAB). It would
exert no direct effect on detrusor muscle, but would attenuate
the release of ATP from nerve-terminals, the transmitter asso-
ciated with OAB in humans. However, to propose an agent as
an in vivo modulator of normal and pathological function
requires a more integrated understanding of its actions. For
example, A1 and A2A receptor agonists modulate nervous
control of the micturition reflex at spinal and supraspinal sites
(Kitta et al. 2012; Kitta et al. 2014).
Study limitations A-receptor ligands were used at high
concentrations with respect to their dose-range on the pri-
mary receptor to ensure a full effect, but they may also
exert non-specific effects via other receptors. Some effects
of actions of adenosine were independent of known A-
receptor sub-types and the basis of this non-specific effect
remains unknown. The limited size of the biopsy samples
limited further investigation of the cell pathways and is the
subject of further studies. The age of NDO patients was
significantly less than that of stable bladder patients, as
expected from the two cohorts of patients from whom sam-
ples were obtained. However, a previous study has record-
ed no age-dependence of basic contractile characteristics
over the ranges recorded here (Fry et al. 2011). Interpreta
tion of the data in terms of adenosine modulating transmit-
ter release from nerve-terminals is indirect using tension as
a primary experimental variable. Direct measurement of
transmitter release from the very small available human
biopsy samples will validate, or otherwise, the conclusions
of this study when sensitive systems become validated.
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